Who is Most Likely to Have High Prescription Drug Costs?
This slideshow explores prescription drug spending for people who are covered by large employer health plans.
View the Latest: Prescription Drugs
Filter
-
-
How Medicare Negotiated Drug Prices Compare to Other Countries
Issue BriefThis analysis finds that Medicare's negotiated prices for 10 high-expenditure prescription drugs are lower than what private Medicare drug plans had been paying, but still much higher than the prices available in 11 other wealthy nations.. It is available on the Peterson-KFF Health System Tracker.
-
What’s Next for Medicare Negotiated Drug Prices Under the Trump Administration?
Quick InsightsThe Trump Administration could go in one of three directions with the Medicare negotiations program: stay the course, water it down or repeal it all together. There are potential tradeoffs with each, but the first would be most popular.
-
Will President Trump’s Executive Order Lower Drug Prices?
Quick InsightsUltimately, assessing the impact of President Trump’s newest iteration of “Most Favored Nation” drug pricing depends on details that have yet to be fleshed out.
-
Americans’ Health Priorities Diverge From Washington’s Focus on Obamacare
News ReleaseIn his latest column for The Wall Street Journal's Think Tank, Drew Altman finds the public’s health-care priorities have more to do with drug costs and other real-world issues people deal with using the health-care system than the ongoing partisan wrangling over the Affordable Care Act. All previous columns by Drew Altman are available online.
-
FAQs on Prescription Drug Importation
Issue BriefThese FAQs address questions related to prescription drug importation, including the current status of importation proposals, details of Florida’s importation program recently authorized by the FDA, and concerns and challenges with this approach.
-
Questions about Prescription Drug Importation? KFF Has Answers
News ReleaseWith lowering prescription drug costs a top priority for Americans, the Trump Administration, presidential candidates, members of Congress, and several states are proposing to allow the importation of drugs from abroad, chiefly Canada. The idea of allowing drugs to be imported from Canada and other countries is popular with Americans across the political spectrum, but has yet to be implemented due to concerns about safety, and strong opposition from the drug industry. A new KFF…
-
Kaiser Health News (KHN) Wins Prestigious Barlett & Steele Investigative Journalism Award
News ReleaseKFF is pleased to announce that Kaiser Health News (KHN), its editorially independent health news service, won a top prize in the 13th annual Barlett & Steele Awards for Investigative Journalism.
-
Most Antiretrovirals Covered by Medicare Part D (as of 2017) Are Brand-Name, Single Source Medications
FeatureMost ARVs Covered by Medicare Part D are Brand Single Source Download
-
Almost Three-Quarters of Antiretrovirals Covered by Medicare Part D Had List Price Increases Above Inflation Between 2016 and 2017
FeatureThree-quarters of Part D ARVs Had Price Increases Above Inflation Download